A crossover clinical trial of piroxicam, indomethacin and ibuprofen in rheumatoid arthritis

References

• De odhar S. D., Dick W. C., Hodgkinson R., Buchanan W. W. Measurement of clinical response to anti-inflammatory drug therapy in rheumatoid arthritis. Q. J. Med. 1973; 42: 3871. De odhar S. D., Dick W. C., Hodgkinson R., Buchanan W. W. Measurement of clinical response to anti-inflammatory drug therapy in rheumatoid arthritis. Q. J. Med. 1973; 42: 387
   PubMedGoogle Scholar
• Lee P., Anderson J. A., Miller J., Webb J., Buchanan W. W. Evaluation of analgesic action and efficacy of anti-rheumatic drugs. J. Rheumatol. 1976; 3: 2832. Lee P., Anderson J. A., Miller J., Webb J., Buchanan W. W. Evaluation of analgesic action and efficacy of anti-rheumatic drugs. J. Rheumatol. 1976; 3: 283
   PubMed Web of Science ®Google Scholar
• Lee P., Baxter A., Dick W. C., Webb J. An assessment of grip-strength measurement in rheumatoid arthritis. Scand. J. Rheumatol. 1974; 3: 173. Lee P., Baxter A., Dick W. C., Webb J. An assessment of grip-strength measurement in rheumatoid arthritis. Scand. J. Rheumatol. 1974; 3: 17
   PubMed Web of Science ®Google Scholar
• Muller-Fassbender H., Schattenkirchner M. Piroxicam in ankylosing spondylitis - an open long term study. R. Soc. Med. Int. Congr. Symp. Ser. 1978, No. 1: 834. Muller-Fassbender H., Schattenkirchner M. Piroxicam in ankylosing spondylitis - an open long term study. R. Soc. Med. Int. Congr. Symp. Ser. 1978, No. 1: 83
   Google Scholar
• Nuki G., Downie W. W., Dick W. C., Whaley K., Spooner J. B., Darby-Dowman M. A., Buchanan W. W. Clinical trial of pentazocine in rheumatoid arthritis. Ann. Rheum. Dis. 1973; 32: 4365. Nuki G., Downie W. W., Dick W. C., Whaley K., Spooner J. B., Darby-Dowman M. A., Buchanan W. W. Clinical trial of pentazocine in rheumatoid arthritis. Ann. Rheum. Dis. 1973; 32: 436
   PubMed Web of Science ®Google Scholar
• Nuotio P., Makisara P. Pharmacokinetic and clinical study of piroxicam. R. Soc. Med. Int. Congr. Symp. Ser. 1978, No. 1: 256. Nuotio P., Makisara P. Pharmacokinetic and clinical study of piroxicam. R. Soc. Med. Int. Congr. Symp. Ser. 1978, No. 1: 25
   Google Scholar
• Nussdorf R. T. Piroxicam and acute musculoskeletal disease - a double blind 14-day study comparing piroxicam and phenylbutazone. R. Soc. Med, Int. Congr. Symp. Ser. 1978, No. 1: 937. Nussdorf R. T. Piroxicam and acute musculoskeletal disease - a double blind 14-day study comparing piroxicam and phenylbutazone. R. Soc. Med, Int. Congr. Symp. Ser. 1978, No. 1: 93
   Google Scholar
• Pitts N. E., Proctor R. R. Summary: efficacy and safety of piroxicam. R. Soc. Med. Int. Congr. Symp. Ser. 1978, No. 1: 978. Pitts N. E., Proctor R. R. Summary: efficacy and safety of piroxicam. R. Soc. Med. Int. Congr. Symp. Ser. 1978, No. 1: 97
   Google Scholar
• Ritchie D. M., Boyle J. A., McInnes J. M., Jasani M. K., Dalakos T. G., Grieveson P., Buchanan W. W. Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. Q. J. Med. 1968; 37: 3939. Ritchie D. M., Boyle J. A., McInnes J. M., Jasani M. K., Dalakos T. G., Grieveson P., Buchanan W. W. Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. Q. J. Med. 1968; 37: 393
   PubMedGoogle Scholar
• Ropes M. W., Bennett G. A., Cobb S., Jacox R, Jessar R. A. Diagnostic criteria for rheumatoid arthritis. 1958 Revision. Ann. Rheum. Dis. 1959; 18: 4910. Ropes M. W., Bennett G. A., Cobb S., Jacox R, Jessar R. A. Diagnostic criteria for rheumatoid arthritis. 1958 Revision. Ann. Rheum. Dis. 1959; 18: 49
   PubMed Web of Science ®Google Scholar
• Steigerwald J. C. Piroxicam and rheumatoid arthritis - a double blind 16-week study comparing piroxicam and indomethacin. R. Soc. Med. Int. Congr. Symp. Ser. 1978, No. 1: 4711. Steigerwald J. C. Piroxicam and rheumatoid arthritis - a double blind 16-week study comparing piroxicam and indomethacin. R. Soc. Med. Int. Congr. Symp. Ser. 1978, No. 1: 47
   Google Scholar
• Tausch G., Eberl R., Brell H. Piroxicam and rheumatoid arthritis long term open treatment. R. Soc. Med. Int. Congr. Symp. Ser. 1978, No. 1: 5912. Tausch G., Eberl R., Brell H. Piroxicam and rheumatoid arthritis long term open treatment. R. Soc. Med. Int. Congr. Symp. Ser. 1978, No. 1: 59
   Google Scholar
• Webb J., Downie W. W., Dick W. C., Lee P. Evaluation of digital joint circumference measurement in rheumatoid arthritis. Scand. J. Rheumatol. 1973; 2: 12713. Webb J., Downie W. W., Dick W. C., Lee P. Evaluation of digital joint circumference measurement in rheumatoid arthritis. Scand. J. Rheumatol. 1973; 2: 127
   PubMedGoogle Scholar
• Wiseman E. H. Review of preclinical studies with piroxicam - pharmacology, pharmacokinetics and toxicology. R. Soc. Med. Int. Congr. Symp. Ser. 1978, No. 1: 1114. Wiseman E. H. Review of preclinical studies with piroxicam - pharmacology, pharmacokinetics and toxicology. R. Soc. Med. Int. Congr. Symp. Ser. 1978, No. 1: 11
   Google Scholar
• Wiseman E. H., Chang Y. H., Lombardino J. G. Piroxicam a novel anti-inflammatory agent. Arzneim. Forsch. 1976; 26: 130015. Wiseman E. H., Chang Y. H., Lombardino J. G. Piroxicam a novel anti-inflammatory agent. Arzneim. Forsch. 1976; 26: 1300
   PubMed Web of Science ®Google Scholar